Search Results
Search for other papers by Se-Min Kim in
Google Scholar
PubMed
Search for other papers by Farhath Sultana in
Google Scholar
PubMed
Search for other papers by Steven Sims in
Google Scholar
PubMed
Search for other papers by Judit Gimenez-Roig in
Google Scholar
PubMed
Search for other papers by Victoria Laurencin in
Google Scholar
PubMed
Search for other papers by Anusha Pallapati in
Google Scholar
PubMed
Search for other papers by Satish Rojekar in
Google Scholar
PubMed
Search for other papers by Tal Frolinger in
Google Scholar
PubMed
Search for other papers by Weibin Zhou in
Google Scholar
PubMed
Search for other papers by Anisa Gumerova in
Google Scholar
PubMed
Search for other papers by Anne Macdonald in
Google Scholar
PubMed
Search for other papers by Vitaly Ryu in
Google Scholar
PubMed
Search for other papers by Daria Lizneva in
Google Scholar
PubMed
Search for other papers by Funda Korkmaz in
Google Scholar
PubMed
Search for other papers by Tony Yuen in
Google Scholar
PubMed
Search for other papers by Mone Zaidi in
Google Scholar
PubMed
mammals. FSHR has been identified in nongonadal reproductive tracts, blood vessels, endothelial cells, the liver, skeletal tissue, bone cells, adipose tissue, and the brain ( Table 1 ). These discoveries have raised the question of whether FSH exerts
Hypothalamic Integration Mechanisms, Netherlands Institute for Neuroscience, Amsterdam, The Netherlands
Search for other papers by Hannah M Eggink in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Centre, Leiden, The Netherlands
Search for other papers by Lauren L Tambyrajah in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Centre, Leiden, The Netherlands
Search for other papers by Rosa van den Berg in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Centre, Leiden, The Netherlands
Search for other papers by Isabel M Mol in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Centre, Leiden, The Netherlands
Search for other papers by Jose K van den Heuvel in
Google Scholar
PubMed
Search for other papers by Martijn Koehorst in
Google Scholar
PubMed
Department of Vascular Medicine, Amsterdam Diabetes Centre, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
Search for other papers by Albert K Groen in
Google Scholar
PubMed
Search for other papers by Anita Boelen in
Google Scholar
PubMed
Hypothalamic Integration Mechanisms, Netherlands Institute for Neuroscience, Amsterdam, The Netherlands
Search for other papers by Andries Kalsbeek in
Google Scholar
PubMed
Search for other papers by Johannes A Romijn in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Centre, Leiden, The Netherlands
Search for other papers by Patrick C N Rensen in
Google Scholar
PubMed
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Centre, Leiden, The Netherlands
Search for other papers by Sander Kooijman in
Google Scholar
PubMed
Search for other papers by Maarten R Soeters in
Google Scholar
PubMed
using immunohistochemistry ( Keitel et al . 2010 ) and FXR was present and active in mouse brain ( Huang et al . 2016 ). The presence of these receptors and their agonists suggest a functional role for BAs in the brain. Considering the well
Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD), University of Cologne, Joseph-Stelzmann-Straße, Cologne, Germany
Search for other papers by Leonie Cabot in
Google Scholar
PubMed
Search for other papers by Juliet Erlenbeck-Dinkelmann in
Google Scholar
PubMed
Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD), University of Cologne, Joseph-Stelzmann-Straße, Cologne, Germany
Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Kerpener Straße, Cologne, Germany
Search for other papers by Henning Fenselau in
Google Scholar
PubMed
Introduction The brain plays an essential role in coordinating feeding behavior and systemic glucose metabolism. For example, the brain determines the timing, composition, and quantity of nutrients that are consumed. On the other hand, it
University of Groningen, University Medical Center, Groningen, The Netherlands
Search for other papers by Marian Joëls in
Google Scholar
PubMed
Search for other papers by E Ronald de Kloet in
Google Scholar
PubMed
, evidence was mounting that there had to be an MR-like receptor co-existing with the classical glucocorticoid receptors (GRs) in the brain. This was discovered in seminal binding studies using 3 H-corticosterone in the absence or presence of the unlabeled
Search for other papers by S Khan in
Google Scholar
PubMed
Centre for Discovery Brain Science, University of Edinburgh, Hugh Robson Building, Edinburgh, UK
Search for other papers by D E W Livingstone in
Google Scholar
PubMed
Search for other papers by A Zielinska in
Google Scholar
PubMed
Search for other papers by C L Doig in
Google Scholar
PubMed
Search for other papers by D F Cobice in
Google Scholar
PubMed
Search for other papers by C L Esteves in
Google Scholar
PubMed
Search for other papers by J T Y Man in
Google Scholar
PubMed
Search for other papers by N Z M Homer in
Google Scholar
PubMed
Search for other papers by J R Seckl in
Google Scholar
PubMed
Search for other papers by C L MacKay in
Google Scholar
PubMed
Search for other papers by S P Webster in
Google Scholar
PubMed
Search for other papers by G G Lavery in
Google Scholar
PubMed
Search for other papers by K E Chapman in
Google Scholar
PubMed
Clinical & Translational Research Institute, Newcastle University, International Centre for Life, Central Parkway, Newcastle upon Tyne, UK
Search for other papers by B R Walker in
Google Scholar
PubMed
Mass Spectrometry Core Laboratory, Edinburgh Clinical Research Facility, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK
Search for other papers by R Andrew in
Google Scholar
PubMed
concept but did not achieve better endpoints than current therapies ( Rosenstock et al. 2010 , Feig et al. 2011 , Shah et al. 2011 , Heise et al. 2014 ). Brain penetrant 11βHSD1 inhibitors have been evaluated as potential therapies for Alzheimer
Biomedical Sciences, University of Missouri, Columbia, Missouri, USA
Search for other papers by Brittney L Marshall in
Google Scholar
PubMed
Informatics Institute, University of Missouri, Columbia, Missouri, USA
Search for other papers by Yang Liu in
Google Scholar
PubMed
Biomedical Sciences, University of Missouri, Columbia, Missouri, USA
Search for other papers by Michelle J Farrington in
Google Scholar
PubMed
Biomedical Sciences, University of Missouri, Columbia, Missouri, USA
Search for other papers by Jiude Mao in
Google Scholar
PubMed
Search for other papers by William G Helferich in
Google Scholar
PubMed
Search for other papers by A Katrin Schenk in
Google Scholar
PubMed
Search for other papers by Nathan J Bivens in
Google Scholar
PubMed
MU Metabolomics Center, University of Missouri, Columbia, Missouri, USA
Search for other papers by Saurav J Sarma in
Google Scholar
PubMed
MU Metabolomics Center, University of Missouri, Columbia, Missouri, USA
Department of Biochemistry, University of Missouri, Columbia, Missouri, USA
Search for other papers by Zhentian Lei in
Google Scholar
PubMed
MU Metabolomics Center, University of Missouri, Columbia, Missouri, USA
Department of Biochemistry, University of Missouri, Columbia, Missouri, USA
Search for other papers by Lloyd W Sumner in
Google Scholar
PubMed
Informatics Institute, University of Missouri, Columbia, Missouri, USA
Department of Health Management and Informatics, School of Medicine, University of Missouri, Columbia, Missouri, USA
Search for other papers by Trupti Joshi in
Google Scholar
PubMed
Biomedical Sciences, University of Missouri, Columbia, Missouri, USA
Informatics Institute, University of Missouri, Columbia, Missouri, USA
Thompson Center for Autism and Neurobehavioral Disorders, University of Missouri, Columbia, Missouri, USA
Genetics Area Program, University of Missouri, Columbia, Missouri, USA
Search for other papers by Cheryl S Rosenfeld in
Google Scholar
PubMed
chemicals can act similarly to estradiol (E2) and presumably disrupt normal developmental processes, including gonad and brain sexual differentiation. Thus, animal model and human epidemiological studies have been initiated to examine how this chemical
Search for other papers by Bruce S McEwen in
Google Scholar
PubMed
Search for other papers by Jason D Gray in
Google Scholar
PubMed
Search for other papers by Carla Nasca in
Google Scholar
PubMed
Introduction The fundamental discovery of the communication between hypothalamus and pituitary, by Geoffrey Harris, established the basis for understanding brain–body communication via the neuroendocrine system ( Harris 1970 ). As originally
Search for other papers by Stijn L J Van Herck in
Google Scholar
PubMed
Search for other papers by Stijn Geysens in
Google Scholar
PubMed
Search for other papers by Edward Bald in
Google Scholar
PubMed
Search for other papers by Grazyna Chwatko in
Google Scholar
PubMed
Search for other papers by Evelyne Delezie in
Google Scholar
PubMed
Search for other papers by Elham Dianati in
Google Scholar
PubMed
Search for other papers by R G Ahmed in
Google Scholar
PubMed
Search for other papers by Veerle M Darras in
Google Scholar
PubMed
embryo/foetus. Maternally derived MMI can block the developing thyroid gland as shown repeatedly in rats ( Comer & Norton 1985 , Ruiz de Ona et al . 1988 , Calvo et al . 1990 ). However, the early vertebrate brain is highly dependent on adequate 3
Center of Brain Research and Rehabilitation, Laboratory of Experimental Endocrinology, Institute of Physiology and Neuroscience, University of Gothenburg, Gothenburg, Sweden
Search for other papers by N David Åberg in
Google Scholar
PubMed
Search for other papers by Inger Johansson in
Google Scholar
PubMed
Search for other papers by Maria A I Åberg in
Google Scholar
PubMed
Search for other papers by Johan Lind in
Google Scholar
PubMed
Search for other papers by Ulf E Johansson in
Google Scholar
PubMed
Search for other papers by Christiana M Cooper-Kuhn in
Google Scholar
PubMed
Search for other papers by H Georg Kuhn in
Google Scholar
PubMed
Search for other papers by Jörgen Isgaard in
Google Scholar
PubMed
studying the mechanistic effects of GH therapy in patients. Subcutaneous GH administered to hypopituitary humans or animals reaches the brain via blood circulation. In principle, GH might affect the brain by directly passing through the blood–brain barrier
Search for other papers by Ferran Jardí in
Google Scholar
PubMed
Gerontology and Geriatrics, Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium
Search for other papers by Michaël R Laurent in
Google Scholar
PubMed
Search for other papers by Vanessa Dubois in
Google Scholar
PubMed
Search for other papers by Nari Kim in
Google Scholar
PubMed
Search for other papers by Rougin Khalil in
Google Scholar
PubMed
Search for other papers by Brigitte Decallonne in
Google Scholar
PubMed
Search for other papers by Dirk Vanderschueren in
Google Scholar
PubMed
Search for other papers by Frank Claessens in
Google Scholar
PubMed
non-reproductive tissues, including brain, muscle, adipose tissue and bone. Testosterone, the principal circulating androgen, may stimulate the androgen receptor (AR) either directly, or indirectly following 5 alpha-reduction to dihydrotestosterone